Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002091
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score 40 Percent and 100 Percent
Sponsor:
Community Research Initiative of New England
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score 40 Percent and 100 Percent
Status:
COMPLETED
Status Verified Date:
1993-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
PRIMARY To determine whether pentoxifylline changes the self-reported measures of quality of life status using measures of scores from double-blinded drug withdrawal and drug restart periods
SECONDARY To measure the changes in monthly CD4 counts fasting serum triglyceride levels and weight to assess the safety of pentoxifylline in HIV-infected persons
SECONDARY To measure the changes in monthly CD4 counts fasting serum triglyceride levels and weight to assess the safety of pentoxifylline in HIV-infected persons
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 91-02 | None | None | None |